PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP

A securities class action has been filed against PROCEPT BioRobotics for allegedly withholding information about handpiece sales practices. The company allegedly used undisclosed bulk order discount programs to artificially inflate sales by pulling forward orders from future quarters, resulting in excess customer inventory exceeding 10,000 units. The stock declined approximately 48% from August 2025 to February 2026 as the company made successive downward revisions and eventually disclosed the inventory issues.